The American pharmaceutical company Pfizer has announced that its experimental vaccine for treating Covid-19 disease is more than 90% effective.
According to Arabiya Net, this is a great victory in the battle against the epidemic that has killed more than a million people and destroyed the global economy and turned daily life patterns upside down. < / p>
Pfizer and its partner, the German biotechnology company Biontech, are the first pharmaceutical companies to publish successful data from a large-scale clinical trial of a coronavirus vaccine.
and the organizers said, according to reports seen by Al Arabiya.net, they would approve a vaccine that is only 50% effective - protecting half of those who get it. The company says there were no serious side effects.
Today is a great day for science and humanity, the first set of results for the third phase of the Covid-19 vaccine trial provides, ”said Dr. Albert Burla, Chairman and CEO of Pfizer. The preliminary evidence for the ability of our vaccine to prevent corona.
We have reached this decisive achievement in our vaccine development program at a time the world needs the most, with infection rates in record numbers.
The discovery that 90% of infections have been prevented by the Pfizer vaccine may spark politicians and public health leaders and potentially put an end to the epidemic.
More than 43,000 people participated in the Phase 3 trials.
and the company says it appears that people with black ethnic backgrounds and minorities are as well protected as everyone else.
Pfizer stated that collecting the required safety data will take until the third week of November, then the file will be submitted to the regulators for approval.
by company; Expedited licensing could mean giving healthcare workers the first doses by the end of the year.
